NCT06195293View on ClinicalTrials.gov

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

December 30, 2029

Study Completion Date

December 30, 2037

Conditions
Solid Tumor, Adult
Interventions
BIOLOGICAL

Neoantigen Polypeptide Vaccine

Deliver neoantigen polypeptide vaccine into patients for anti-ancer therapy.

Trial Locations (1)

510260

RECRUITING

Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER